Honeywell International’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-217,100
Closed -$12.1M 166
2017
Q2
$12.1M Sell
217,100
-440,000
-67% -$23.9M 0.46% 90
2017
Q1
$35.7M Sell
657,100
-442,100
-40% -$24.2M 1.15% 19
2016
Q4
$64.2M Buy
1,099,200
+61,800
+6% +$3.38M 2.15% 5
2016
Q3
$55.9M Buy
1,037,400
+335,000
+48% +$21.5M 1.95% 5
2016
Q2
$51.7M Buy
702,400
+3,100
+0.4% +$219K 1.32% 18
2016
Q1
$44.7M Buy
699,300
+290,200
+71% +$18.3M 1.13% 22
2015
Q4
$28.1M Buy
409,100
+65,100
+19% +$4.3M 0.71% 53
2015
Q3
$20.4M Sell
344,000
-6,500
-2% -$412K 0.55% 78
2015
Q2
$23.3M Sell
350,500
-89,200
-20% -$5.88M 0.57% 68
2015
Q1
$28.4M Sell
439,700
-1,600
-0.4% -$100K 0.67% 59
2014
Q4
$26M Sell
441,300
-218,700
-33% -$12.3M 0.59% 70
2014
Q3
$33.8M Buy
+660,000
New +$33M 0.79% 32

Other funds holding BMY

Honeywell International's BMY Position: Q3 2017 in Review

Honeywell International sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 217,100 shares — an estimated $12.1M sold.

Honeywell International first reported a position in BMY in Q3 2014 and held it in 12 quarters. The position peaked at $64.2M in Q4 2016. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Honeywell International reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
  • Honeywell International sold 217,100 Bristol-Myers Squibb shares in Q3 2017, an estimated $12.1M.
  • Honeywell International first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 12 quarters.
  • Honeywell International's Bristol-Myers Squibb position peaked at $64.2M in Q4 2016.
  • 1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Honeywell International's 13F filing for Q3 2017, filed 26 Oct 2017.